Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Multiple Sclerosis × nabiximols × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Pain 6 Neoplasms 6 Cancer Pain 3 Marijuana Abuse 2 Neuralgia 1 Multiple Sclerosis 1 Diabetes Mellitus 1 Chronic Pain 1

Interventions

fludarabine 2 Interferon beta-1b 2 Cyclophosphamide 2 nabiximols 1 Natalizumab 1 Mn-PyC3A 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02073474 2022-12-20

An Observational Post-Marketing Safety Registry of Sativex®

Jazz Pharmaceuticals

Marijuana Abuse, Diabetes Mellitus, Multiple Sclerosis, Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡